1410. Cholera: An Ancient Scourge but Still a Modern Problem
Session: Plenary Session: Presidential Plenary Session: Cholera - A Recurring Menace
Sunday, October 23, 2011: 9:45 AM
Room: Grand Ballroom (East-West)

Stephen B. Calderwood, MD, FIDSA, Massachusetts General Hospital, Boston, MA

Stephen B. Calderwood, M.D.
Chief, Division of Infectious Diseases, Massachusetts General Hospital
Morton N. Swartz Academy Professor of Medicine (Microbiology and Molecular Genetics), Harvard Medical School
Dr. Calderwood received his Bachelor of Science degree from Harvard University (1971) and his M. D. degree from Harvard Medical School (1975). He did medical residency training at the Massachusetts General Hospital, as well as Clinical and Research Fellowship in Infectious Diseases and Chief Residency at MGH, before joining the faculty there and at Harvard in 1982. He did additional laboratory research training with Dr John Mekalanos at Harvard Medical School, before establishing his own research laboratory at the Massachusetts General Hospital in 1988. Dr. Calderwood’s research interests focus on microbial pathogenesis, microbial-host interactions, regulation of gene expression in the human host, and vaccine development. He is the Principal Investigator of an International Collaborations in Infectious Disease Research grant focused on cholera with the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh. Dr. Calderwood is a Scholar in the Academy at Harvard Medical School, teaches microbial pathogenesis and infectious diseases in all four years of the curriculum at Harvard Medical School, is on the medical education reform steering committee at Harvard, directs the Principal Clinical Experience for third year Harvard Medical students at the Massachusetts General Hospital. Dr. Calderwood is the Vice Chair of the Department of Medicine at the Massachusetts General Hospital, and oversees education of students, residents, fellows and post-graduate education in the department. Dr. Calderwood is a Fellow of the American College of Physicians, the Infectious Diseases Society of America, the American Academy of Microbiology, and the American Association for the Advancement of Science. He has published over 140 journal articles and book chapters on a variety of topics related to infectious disease and microbiology. His clinical interests are in antimicrobial agents, gastrointestinal infections, endocarditis, central nervous system infections, and biodefense.

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.